When Does “Access” Become “Established” in Rare Diseases?

When Does “Access” Become “Established” in Rare Diseases?

  • ISPOR 2021 EU
  • Jan 2023
Balancing Earlier Access and Data Immaturity – Are New Methods the Key?

Balancing Earlier Access and Data Immaturity – Are New Methods the Key?

  • ISPOR 2021 EU
  • Jan 2023
Costello Medical ISMPP EU Report 2022

Costello Medical ISMPP EU Report 2022

  • ISMPP 2022 EU
  • Nov 2022
Costello Medical ISPOR Annual Meeting Report 2020

Costello Medical ISPOR Annual Meeting Report 2020

  • ISPOR US 2020
  • Jun 2020
Costello Medical ISMPP EU Report 2020

Costello Medical ISMPP EU Report 2020

  • ISMPP 2020 EU
  • Mar 2020
Costello Medical ISPOR Copenhagen Report 2019

Costello Medical ISPOR Copenhagen Report 2019

  • ISPOR 2019 Copenhagen
  • Dec 2019
Costello Medical ISMPP Asia-Pacific 2019 Report

Costello Medical ISMPP Asia-Pacific 2019 Report

  • ISMPP 2019 Asia-Pacific
  • Nov 2019
Costello Medical ISPOR US Report 2019

Costello Medical ISPOR US Report 2019

  • ISPOR 2019 New Orleans
  • Jul 2019
NICE Consultation on Proposed Changes to the Technology Appraisal Programme Phase 2

NICE Consultation on Proposed Changes to the Technology Appraisal Programme Phase 2

  • Feb 2018
ISMPP European Meeting, London 2018

ISMPP European Meeting, London 2018

  • Feb 2018
ISPOR 20th Annual European Congress, Glasgow 2017

ISPOR 20th Annual European Congress, Glasgow 2017

  • Dec 2017
HTAi 14th Annual Meeting, Rome 2017

HTAi 14th Annual Meeting, Rome 2017

  • Jun 2017
Loading